| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11541012 | ACROTECH BIOPHARMA | Compositions comprising disodium levofolinate |
Mar, 2039
(15 years from now) | |
Khapzory is owned by Acrotech Biopharma.
Khapzory contains Levoleucovorin.
Khapzory has a total of 1 drug patent out of which 0 drug patents have expired.
Khapzory was authorised for market use on 19 October, 2018.
Khapzory is available in powder;intravenous dosage forms.
The generics of Khapzory are possible to be released after 25 March, 2039.
Drugs and Companies using LEVOLEUCOVORIN ingredient
Market Authorisation Date: 19 October, 2018
Treatment: NA
Dosage: POWDER;INTRAVENOUS
More Information on Dosage
KHAPZORY family patents
